Business description
Captor Therapeutics is a biopharmaceutical company focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Management board & Supervisory board
| CEO |
| Thomas Shepherd |
| Management board |
| Thomas Shepherd, Radosław Krawczyk, Michał Walczak |
| Supervisory board |
| Paweł Holstinghausen Holsten, Robert Florczykowski, Florent Gros, Krzysztof Samotij, Maciej Wróblewski |
Company data
| Name: |
Captor Therapeutics S.A. |
| Address: |
ul. Duńska 11,54-427 Wrocław |
| Phone: |
+48 537 869 089 |
| Fax: |
- |
| E-mail: |
info@captortherapeutics.com
|
| Internet: |
https://www.captortherapeutics.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
- |
| End of financial year: |
12-31 |
| Free Float: |
53.60% |
| IPO date: |
2021-04-19 |
